Exhibit 32.2




In connection with this Annual Report of MusclePharm Corporation (the “Company”), on Form 10-K/A for the year ended December 31, 2013, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Donald W Prosser Principal Accounting Officer of the Company, certify pursuant to 18 U.S.C. Section. 1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that:


(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and


(2)The information contained in the Report, fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: October 31, 2014 By: /s/ Donald W. Prosser  
    Donald W. Prosser  
    Principal Accounting Officer